Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0021400,
umls-concept:C0026809,
umls-concept:C0028612,
umls-concept:C0030956,
umls-concept:C0038952,
umls-concept:C0039195,
umls-concept:C0042776,
umls-concept:C0178602,
umls-concept:C0205263,
umls-concept:C0805586,
umls-concept:C0871261,
umls-concept:C1280500,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1883254,
umls-concept:C2911692
|
pubmed:issue |
14
|
pubmed:dateCreated |
1995-3-16
|
pubmed:abstractText |
Even though virus-induced cytotoxic T lymphocytes (CTLs) recognize antigens as peptides presented on infected cells, short synthetic peptides without any modifications are generally considered unsuitable for inducing antigen-specific CTLs in vivo. Our results demonstrate rapid induction of influenza virus-specific CTLs in Balb/c mice by an unmodified core protein peptide known to be a dominant H-2d-restricted CTL epitope. Additionally, the immunization procedure we employed in these studies produced significant influenza virus-specific CTLs in lymph nodes, spleen and lungs. When challenged with a lethal dose of influenza virus, a statistically significant delay in the day of death was observed in peptide-immunized mice. However, viral clearance was only slightly different from that in control mice. While these results are encouraging, they suggest a requirement for multiple CTL-inducing peptides, helper T cell-inducing peptides and/or virus-specific IgA responses in order to achieve protection from influenza infection.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1281-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7856292-Amino Acid Sequence,
pubmed-meshheading:7856292-Animals,
pubmed-meshheading:7856292-Cell Line,
pubmed-meshheading:7856292-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:7856292-Influenza A virus,
pubmed-meshheading:7856292-Influenza Vaccines,
pubmed-meshheading:7856292-Lymph Nodes,
pubmed-meshheading:7856292-Mice,
pubmed-meshheading:7856292-Mice, Inbred BALB C,
pubmed-meshheading:7856292-Molecular Sequence Data,
pubmed-meshheading:7856292-Nucleoproteins,
pubmed-meshheading:7856292-Orthomyxoviridae Infections,
pubmed-meshheading:7856292-Peptide Fragments,
pubmed-meshheading:7856292-Spleen,
pubmed-meshheading:7856292-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:7856292-Viral Core Proteins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus.
|
pubmed:affiliation |
Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|